Tetrahydroxystilbene glycoside antagonizes β-amyloid-induced inflammatory injury in microglia cells by regulating PU.1 expression

Chenli Jiao,F. Gao,L. Ou,Jinhua Yu,Min Li,P. Wei,F. Miu

Published 2018 in NeuroReport

ABSTRACT

Inhibiting &bgr;-amyloid (A&bgr;)-induced microglial activation is proposed as an effective strategy for the treatment of Alzheimer’s disease. Tetrahydroxystilbene glycoside (TSG) is the main active ingredient of Polygonum multiflorum and has a wide range of biological properties, including antiinflammation. Here, we focused on the function and regulatory mechanism of TSG in A&bgr;-induced N9 and BV2 cells. The results showed that A&bgr; treatment induced the activation of microglia cells and the production of inflammatory molecules, including inducible nitric oxide synthase, nitric oxide, cyclooxygenase 2, and prostaglandin E2, which were significantly inhibited by TSG pretreatment. Furthermore, we found A&bgr; exposure increased the levels of microglial M1 markers, interleukin (IL)-1&bgr;, IL-6, and tumor necrosis factor &agr;, and the pretreatment of TSG suppressed the increase of M1 markers and enhanced the levels of M2 markers, including IL-10, brain-derived neurotrophic factor, glial cell-derived neurotrophic factor, and arginase-1. PU.1 overexpression was found to eradicate the anti-inflammatory effects of TSG in A&bgr;-induced microglial cells. Taken together, these findings indicate that TSG attenuates A&bgr;-induced microglial activation and polarizes microglia towards M2 phenotype, which may be closely associated with the regulation of PU.1.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-26 of 26 references · Page 1 of 1

CITED BY

Showing 1-18 of 18 citing papers · Page 1 of 1